Cullen/Frost Bankers’s Globus Medical GMED Stock Holding History

Cullen/Frost Bankers’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,600	Closed	-$258K	–	1385
2024 Q3	$258K	Hold	3,600	–	–	﹤0.01%	464
2024 Q2	$247K	Hold	3,600	–	–	﹤0.01%	459
2024 Q1	$193K	Hold	3,600	–	–	﹤0.01%	492
2023 Q4	$192K	Hold	3,600	–	–	﹤0.01%	487
2023 Q3	$179K	Hold	3,600	–	–	﹤0.01%	516
2023 Q2	$214K	Sell	3,600 -1,300	-27%	-$74.1K	﹤0.01%	494
2023 Q1	$278K	Hold	4,900	–	–	0.01%	461
2022 Q4	$364K	Hold	4,900	–	–	0.01%	424
2022 Q3	$292K	Hold	4,900	–	–	0.01%	451
2022 Q2	$275K	Hold	4,900	–	–	0.01%	463
2022 Q1	$362K	Hold	4,900	–	–	0.01%	445
2021 Q4	$354K	Sell	4,900 -452	-8%	-$32.8K	0.01%	456
2021 Q3	$410K	Hold	5,352	–	–	0.01%	421
2021 Q2	$415K	Buy	5,352 +452	+9%	+$32.1K	0.01%	426
2021 Q1	$302K	Hold	4,900	–	–	0.01%	466
2020 Q4	$320K	Hold	4,900	–	–	0.01%	421
2020 Q3	$243K	Hold	4,900	–	–	0.01%	434
2020 Q2	$234K	Hold	4,900	–	–	0.01%	425
2020 Q1	$208K	Hold	4,900	–	–	0.01%	357
2019 Q4	$289K	Buy	+4,900	New	+$266K	0.01%	376

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cullen/Frost Bankers's GMED Position: Q4 2024 in Review

Cullen/Frost Bankers sold out of Globus Medical (GMED) in Q4 2024, closing a stake of 3,600 shares — an estimated $258K sold.

Cullen/Frost Bankers first reported a position in GMED in Q4 2019 and held it in 20 quarters. The position peaked at $415K in Q2 2021. 500 funds tracked by Wall St. Rank hold GMED as of Q4 2024.

Cullen/Frost Bankers reported no remaining Globus Medical position as of Q4 2024 after selling out during the quarter.
Cullen/Frost Bankers sold 3,600 Globus Medical shares in Q4 2024, an estimated $258K.
Cullen/Frost Bankers first reported a position in Globus Medical in Q4 2019 and held it in 20 quarters.
Cullen/Frost Bankers's Globus Medical position peaked at $415K in Q2 2021.
500 funds tracked by Wall St. Rank held Globus Medical as of Q4 2024.

Based on Cullen/Frost Bankers's 13F filing for Q4 2024, filed 6 Feb 2025.